APA (7th ed.) Citation

GA, S., NT, T., P, K., A, V., PP, M., A, P., . . . PJ, M. (2018). Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest, 154(3), 491. https://doi.org/10.1016/j.chest.2018.02.012

Chicago Style (17th ed.) Citation

GA, Silvestri, et al. "Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial." Chest 154, no. 3 (2018): 491. https://doi.org/10.1016/j.chest.2018.02.012.

MLA (9th ed.) Citation

GA, Silvestri, et al. "Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial." Chest, vol. 154, no. 3, 2018, p. 491, https://doi.org/10.1016/j.chest.2018.02.012.